<![CDATA[AOP Orphan Pharmaceuticals AG 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=37341>Wed, 29 Apr 2026 14:37:27 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera to Be Presented at the American Society of Hematology (ASH) 65th Annual Meeting]]>https://www.newswire.co.kr/newsRead.php?no=980585Fri, 08 Dec 2023 14:15:00 +0900<![CDATA[AOP 헬스, 미국 혈액학회 제65차 연례 회의에서 진성 적혈구증가증 환자에 대한 새로운 발견 공개]]>https://www.newswire.co.kr/newsRead.php?no=980586Fri, 08 Dec 2023 14:15:00 +0900<![CDATA[German Federal Court of Justice Upholds AOP‘s License Rights in Ropeginterferon and PEC’s Liability for Damages.]]>https://www.newswire.co.kr/newsRead.php?no=939589Wed, 16 Feb 2022 10:03:12 +0900<![CDATA[독일연방법원, AOP의 로페그인터페론 라이선스 권리 인정 및 PEC에 손해 배상 명령]]>https://www.newswire.co.kr/newsRead.php?no=939590Wed, 16 Feb 2022 10:02:02 +0900<![CDATA[BESREMi® (Ropeginterferon alfa-2b) approved by the US FDA]]>https://www.newswire.co.kr/newsRead.php?no=934503Tue, 16 Nov 2021 13:50:00 +0900<![CDATA[베스레미(로페그인터페론 알파-2b), 미국 FDA 승인 획득]]>https://www.newswire.co.kr/newsRead.php?no=934504Tue, 16 Nov 2021 13:50:00 +0900<![CDATA[AOP Orphan reports full validity of arbitral award against PharmaEssentia]]>https://www.newswire.co.kr/newsRead.php?no=920689Fri, 26 Mar 2021 17:15:00 +0900<![CDATA[AOP 오펀, 파마에센시아가 제기한 중재 판정 취소 소송서 승소]]>https://www.newswire.co.kr/newsRead.php?no=920690Fri, 26 Mar 2021 17:15:00 +0900